Cargando…

Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways

The aim of the present study is to elucidate the neuronal pathways associated to NSAIDs causing a reduction of the risk and progression of Alzheimer's disease. The research was developed administering the active enantiomer of ibuprofen, dexibuprofen (DXI), in order to reduce associated gastric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ettcheto, Miren, Sánchez-López, Elena, Pons, Laura, Busquets, Oriol, Olloquequi, Jordi, Beas-Zarate, Carlos, Pallas, Merce, García, Maria Luisa, Auladell, Carme, Folch, Jaume, Camins, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480981/ https://www.ncbi.nlm.nih.gov/pubmed/28646794 http://dx.doi.org/10.1016/j.redox.2017.06.003

Ejemplares similares

Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
por: Ettcheto, Miren, et al.
Publicado: (2021)

Experimental Models for Aging and their Potential for Novel Drug Discovery
por: Folch, Jaume, et al.
Publicado: (2018)

Involvement of JNK1 in Neuronal Polarization During Brain Development
por: Castro-Torres, Rubén Darío, et al.
Publicado: (2020)

Current Research Therapeutic Strategies for Alzheimer's Disease Treatment
por: Folch, Jaume, et al.
Publicado: (2016)

The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
por: Folch, Jaume, et al.
Publicado: (2019)

Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
por: Folch, Jaume, et al.
Publicado: (2018)

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia
por: Folch, Jaume, et al.
Publicado: (2018)

Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
por: Ettcheto, Miren, et al.
Publicado: (2020)

Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment
por: Busquets, Oriol, et al.
Publicado: (2019)

JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function
por: Busquets, Oriol, et al.
Publicado: (2022)

Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2022)

Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
por: Ettcheto, Miren, et al.
Publicado: (2019)

Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
por: Cano, Amanda, et al.
Publicado: (2019)

A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2023)

Dual Mkk4 and Mkk7 Gene Deletion in Adult Mouse Causes an Impairment of Hippocampal Immature Granule Cells
por: Castro-Torres, Rubén Darío, et al.
Publicado: (2021)

Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
por: Olloquequi, Jordi, et al.
Publicado: (2023)

Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study
por: Sánchez-López, Elena, et al.
Publicado: (2020)

A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286
por: Pizarro, Javier G, et al.
Publicado: (2009)

Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases
por: Camins, Antoni, et al.
Publicado: (2009)

Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
por: Poor, Saghar Rabiei, et al.
Publicado: (2021)

Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease
por: Rabieipoor, Saghar, et al.
Publicado: (2023)

Dexibuprofen Therapeutic Advances: Prodrugs and Nanotechnological Formulations
por: Gliszczyńska, Anna, et al.
Publicado: (2021)

Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector
por: Khan, Jahangir, et al.
Publicado: (2018)

Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges
por: Cano, Amanda, et al.
Publicado: (2023)

Pharmacokinetic-Pharmacodynamic Model of Newly Developed Dexibuprofen Sustained Release Formulations
por: Muralidharan, Selvadurai
Publicado: (2012)

Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers
por: Thiruchenthooran, Vaikunthavasan, et al.
Publicado: (2022)

The Cross Talk between Underlying Mechanisms of Multiple Sclerosis and Epilepsy May Provide New Insights for More Efficient Therapies
por: Rayatpour, Atefeh, et al.
Publicado: (2021)

YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice
por: Wang, Xiaowan, et al.
Publicado: (2017)

Synthesis, Bioevaluation and Molecular Dynamic Simulation Studies of Dexibuprofen–Antioxidant Mutual Prodrugs
por: Ashraf, Zaman, et al.
Publicado: (2016)

Lipid Nanoparticles for the Posterior Eye Segment
por: Bonilla, Lorena, et al.
Publicado: (2021)

Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation
por: Galindo, Ruth, et al.
Publicado: (2022)

Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges
por: Bonilla, Lorena, et al.
Publicado: (2021)

Development and Validation of a HPLC and an UV Spectrophotometric Methods for Determination of Dexibuprofen in Pharmaceutical Preparations
por: Muralidharan, Selvadurai, et al.
Publicado: (2011)

Dexibuprofen nanocrystals with improved therapeutic performance: fabrication, characterization, in silico modeling, and in vivo evaluation
por: Ullah, Naseem, et al.
Publicado: (2018)

Enhanced Solubility and Biological Activity of Dexibuprofen-Loaded Silica-Based Ternary Solid Dispersions
por: Asim, Muhammad, et al.
Publicado: (2023)

Extracellular vesicles, the emerging mirrors of brain physiopathology
por: Cano, Amanda, et al.
Publicado: (2023)

Understanding the Role of Hypoxia Inducible Factor During Neuro-degeneration for New Therapeutics Opportunities
por: Merelli, Amalia, et al.
Publicado: (2018)

Design, Development, and Optimization of Dexibuprofen Microemulsion Based Transdermal Reservoir Patches for Controlled Drug Delivery
por: Ali, Fatima Ramzan, et al.
Publicado: (2017)

KB-R7943 reduces 4-aminopyridine-induced epileptiform activity in adult rats after neuronal damage induced by neonatal monosodium glutamate treatment
por: Hernandez-Ojeda, Mariana, et al.
Publicado: (2017)

Effects of Nutrition on Cognitive Function in Adults with or without Cognitive Impairment: A Systematic Review of Randomized Controlled Clinical Trials
por: Gutierrez, Laia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fm7u173vfr9hacu3t5onkoo9i8